•
Mar 31, 2020

Natera Q1 2020 Earnings Report

Reported record revenues and test volumes, and drove cost of goods sold per unit near the long-term target.

Key Takeaways

Natera reported a strong first quarter with record revenues of $94.0 million, a 41% increase compared to the first quarter of 2019. The company also processed 235,500 tests and achieved higher gross margins due to increased volume and average selling price.

Total revenues were $94.0 million, a 41% increase compared to Q1 2019.

Processed 235,500 tests, including approximately 222,400 tests accessioned in its laboratory.

Gross profit was $49.0 million, representing a 52% gross margin.

Net loss was $35.4 million, or ($0.45) per diluted share.

Total Revenue
$94M
Previous year: $66.8M
+40.7%
EPS
-$0.45
Previous year: -$0.54
-16.7%
Tests Processed
235.5K
Previous year: 200.2K
+17.6%
Tests Accessioned
222.4K
Previous year: 186.5K
+19.2%
Total Tests Reported
221.5K
Previous year: 184.7K
+19.9%
Gross Profit
$49M
Previous year: $23.5M
+108.3%
Cash and Equivalents
$406M
Previous year: $34.3M
+1084.0%

Natera

Natera

Forward Guidance

Natera has withdrawn its financial guidance for the 2020 fiscal year due to the highly dynamic situation and ongoing disruptions from COVID-19.